Pharma Journalist -

Roche announced the launch of the DISCOVERY Teal HRP kit, the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell…
Read More...

Alcami Corporation announces the official opening of a new West Coast sales office in the heart of La Jolla at 4660 La Jolla Village Drive, Suite 100, San Diego, California. The…
Read More...

Purdue Pharma L.P. today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet…
Read More...

Syngene International announced that it has expanded its ongoing collaboration with Bristol-Myers Squibb. The next phase of the partnership will see the addition of a new facility to…
Read More...

Ascentage Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for APG-1387, a novel small molecule IAP…
Read More...

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech, a member of the Roche Group, for the development of new therapeutics using Arvinas' novel PROTAC…
Read More...

SMi reports: Abbvie and Astrazeneca to present keynote address’ at SMi’s Drug Discovery conference taking place in London on 21st-22nd March 2018 Abbvie and Astrazeneca will present…
Read More...

Evonik is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. It now offers RESOMER Zero and RESOMER Sterile versions of both…
Read More...

Theravance Biopharma and Mylan announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for revefenacin (TD-4208), an investigational…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance…
Read More...